The Lancet Infectious Diseases is a monthly journal, renowned for the publication of high-quality peer-reviewed reviews and analysis from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue.
…
continue reading
Saleha Hassan, Senior Editor at The Lancet Infectious Diseases, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from polio eradication in Africa to COVID-19 vaccines in Hong Kong, the treatment of early syphilis in adults to Mpox in the UK, and more.
…
continue reading

1
Jan Felix Drexler and Fernando Bozza on Oropouche virus
35:17
35:17
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
35:17Jan Felix Drexler and Fernando Bozza discuss their recent study published in the journal— “The spatio-temporal ecology of Oropouche virus: a laboratory-based modelling study across Latin America” and its wider implications for Oropouche virus and other arboviruses transmission, expansion, surveillance, and control. Read the full article: https://ww…
…
continue reading

1
In conversation with... Jan Felix Drexler and Fernando Bozza
35:17
35:17
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
35:17Jan Felix Drexler and Fernando Bozza discuss their recent study published in the journal— “The spatio-temporal ecology of Oropouche virus: a laboratory-based modelling study across Latin America” and its wider implications for Oropouche virus and other arboviruses transmission, expansion, surveillance, and control.…
…
continue reading

1
In Conversation With… Prasad Kulkarni on a dengue monoclonal antibody
18:53
18:53
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
18:53Prasad Kulkarni discusses a new Phase I trial in The Lancet Infectious Diseases on a dengue monoclonal antibody also known as VIS513 in healthy adults. In addition, he highlights the wider implications of this for dengue control and drug development.بقلم The Lancet
…
continue reading

1
Prasad Kulkarni on dengue monoclonal antibodies
18:53
18:53
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
18:53Prasad Kulkarni discusses a new Phase I trial in The Lancet Infectious Diseases on a dengue monoclonal antibody also known as VIS513 in healthy adults. In addition, he highlights the wider implications of this for dengue control and drug development. Read the full article: https://www.thelancet.com/journals/laninf/article/ S1473-3099(24)00030-6/ful…
…
continue reading
Oriol Mitjà discusses a new trial in The Lancet Infectious Diseases on the use of oral linezolid compared with benzathine penicillin G for the treatment of early syphilis in adults. He also highlights what the trial means for treatment of syphilis.بقلم The Lancet
…
continue reading

1
Oriol Mitjà on treatment of early syphilis in adults
15:25
15:25
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
15:25Oriol Mitjà discusses a new trial in The Lancet Infectious Diseases on the use of oral linezolid compared with benzathine penicillin G for the treatment of early syphilis in adults. He also highlights what the trial means for treatment of syphilis. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00683-7/ful…
…
continue reading

1
In conversation with... Sofia Viegas and Stefan Niemann
24:35
24:35
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
24:35Sofia Viegas and Stefan Niemann discuss a new article in The Lancet Infectious Diseases about emerging bedaquiline resistance in Mozambique and its implications for drug resistant tuberculosis and the fight to end tuberculosis.بقلم The Lancet
…
continue reading

1
Sofia Viegas and Stefan Niemann on emerging bedaquiline resistance in Mozambique
24:35
24:35
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
24:35Sofia Viegas and Stefan Niemann discuss a new article in The Lancet Infectious Diseases about emerging bedaquiline resistance in Mozambique and its implications for drug resistant tuberculosis and the fight to end tuberculosis. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00498-X/fulltext?dgcid=buzzsprou…
…
continue reading

1
In conversation with... Luciano Moreira and Henrik Salje
17:01
17:01
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
17:01Luciano Moreira and Henrik Salje discuss a new article in The Lancet Infectious Diseases describing the use of the Wolbachia bacteria to control the spread of mosquito-borne dengue and chikungunya in Rio de Janeiro, Brazil.بقلم The Lancet
…
continue reading

1
Luciano Moreira and Henrik Salje on Wolbachia control of mosquito-borne infections
17:01
17:01
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
17:01Luciano Moreira and Henrik Salje discuss a new article in The Lancet Infectious Diseases describing the use of the Wolbachia bacteria to control the spread of mosquito-borne dengue and chikungunya in Rio de Janeiro, Brazil. Read the full article: Estimating the effect of the wMel release programme on the incidence of dengue and chikungunya in Rio d…
…
continue reading

1
Richard Maude on malaria chemoprophylaxis in Cambodia
12:44
12:44
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
12:44Richard Maude discusses a new article in The Lancet Infectious Diseases that assesses the efficacy of malaria chemoprophylaxis among forest goers in Cambodia. Read the full article: Antimalarial chemoprophylaxis for forest goers in southeast Asia Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://inst…
…
continue reading

1
In conversation with... Richard Maude
12:44
12:44
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
12:44Richard Maude discusses a new article in The Lancet Infectious Diseases that assesses the efficacy of malaria chemoprophylaxis among forest goers in Cambodia.بقلم The Lancet
…
continue reading

1
Ben Cowling on COVID-19 vaccines in Hong Kong
20:58
20:58
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
20:58Ben Cowling discusses a new article in The Lancet Infectious Diseases describing the protection that vaccines are providing against COVID-19 in Hong Kong. Read the full article: Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong Continue this conversation on social! Follow us today at... https…
…
continue reading
Ben Cowling discusses a new article in The Lancet Infectious Diseases describing the protection that vaccines are providing against COVID-19 in Hong Kong.بقلم The Lancet
…
continue reading
Hugh Adler discusses a new article in The Lancet Infectious Diseases describing the management and the clinical features for seven patients with monkeypox hospitalised in the UK between 2018 and 2021. Read the full article: Clinical features and management of human monkeypox: a retrospective observational study in the UK Continue this conversation …
…
continue reading
Hugh Adler discusses a new article in The Lancet Infectious Diseases describing the management and the clinical features for seven patients with monkeypox hospitalised in the UK between 2018 and 2021.بقلم The Lancet
…
continue reading

1
In conversation with... Beate Kampmann, Karen Keddy, and Peter Ghazal
22:16
22:16
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
22:16Prof Beate Kampmann, Dr Karen Keddy, and Prof Peter Ghazal discuss a new cross-journal Series in The Lancet Infectious Diseases and EBioMedicine addressing the potential for and challenge of applying big data to childhood infectious diseases in LMICsبقلم The Lancet
…
continue reading

1
Beate Kampmann, Karen Keddy, and Peter Ghazal on applying big data to childhood infectious diseases in LMICs
22:16
22:16
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
22:16Prof Beate Kampmann, Dr Karen Keddy, and Prof Peter Ghazal discuss a new cross-journal Series in The Lancet Infectious Diseases and EBioMedicine addressing the potential for and challenge of applying big data to childhood infectious diseases in LMICs. Read the full Series: https://www.thelancet.com/series/big-data-childhood-infections-LMICs Continu…
…
continue reading

1
Laura Cooper and Sam Okiror on polio eradication in Africa
21:34
21:34
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
21:34A new article highlights how changing immunity profiles motivate the need for better responses to outbreaks of polio in Africa. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00453-9/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/th…
…
continue reading

1
In conversation with... Laura Cooper and Sam Okiror
21:34
21:34
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
21:34A new Article in The Lancet Infectious Diseases highlights how changing immunity profiles motivate the need for better responses to outbreaks of polio in Africa.بقلم The Lancet
…
continue reading

1
In conversation with... Paul Chapman
20:57
20:57
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
20:57Paul Chapman and colleagues presents the results of an innovative trial assessing the safety of vaccinating healthy volunteers with attenuated Necator americanus hookworm larvae.بقلم The Lancet
…
continue reading
Paul Chapman and colleagues presents the results of an innovative trial assessing the safety of vaccinating healthy volunteers with attenuated Necator americanus hookworm larvae. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00153-5/fulltext Continue this conversation on social! Follow us today at... http…
…
continue reading
Josep Llibre discusses a trial on the impact of same-day testing for SARS-CoV-2 infection before a concert on new COVID-19 cases in Ba rcelona, Spain.بقلم The Lancet
…
continue reading

1
Josep Llibre on preventing SARS-CoV-2 transmission at concerts
8:10
8:10
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
8:10Josep Llibre discusses a trial on the impact of same-day testing for SARS-CoV-2 infection before a concert on new COVID-19 cases in Barcelona, Spain. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00268-1/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ ht…
…
continue reading
Yap Boum (MSF) discusses his study done in Cameroon, which developed a promising testing strategy for COVID-19 to optimise the available resource.بقلم The Lancet
…
continue reading

1
Yap Boum on COVID-19 testing in low resource settings
11:21
11:21
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
11:21Yap Boum (MSF) discusses his study done in Cameroon, which developed a promising testing strategy for COVID-19 to optimise the available resources. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00132-8/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ http…
…
continue reading

1
Antimalarial resistance in southeast Asia
13:12
13:12
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
13:12Two studies in The Lancet Infectious Diseases describe how the spread of resistance to both dihydroartemisinin and piperaquine is compromising malaria therapy in South-East Asiaبقلم The Lancet
…
continue reading

1
Antimalarial resistance in southeast Asia
13:06
13:06
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
13:06Two studies in The Lancet Infectious Diseases describe how the spread of resistance to both dihydroartemisinin and piperaquine is compromising malaria therapy in South-East Asia Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal…
…
continue reading

1
Trial in phage therapy for burn infections
29:57
29:57
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
29:57A trial investigates the use of a cocktail of phages for the therapy of infections in patients with burns.بقلم The Lancet
…
continue reading

1
Trial in phage therapy for burn infections
29:29
29:29
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
29:29A trial investigates the use of a cocktail of phages for the therapy of infections in patients with burns. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancett…
…
continue reading
Editor of The Lancet Infectious Diseases, John McConnell, discusses the 1918 influenza pandemic and the lessons that can be learnt from it with John Oxford and Jeffery Taubenberger.بقلم The Lancet
…
continue reading
Editor of The Lancet Infectious Diseases, John McConnell, discusses the 1918 influenza pandemic and the lessons that can be learnt from it with John Oxford and Jeffery Taubenberger. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljou…
…
continue reading

1
Bedaquiline and delamanid combination for drug-resistant TB: The Lancet Infectious Diseases: February 13, 2018
15:16
15:16
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
15:16Amir Shroufi discusses the early results assessing the safety and efficacy of the combination of bedaquiline and delamanid against drug-resistant tuberculosis.بقلم The Lancet
…
continue reading

1
Bedaquiline and delamanid combination for drug-resistant TB: The Lancet Infectious Diseases: February 13, 2018
14:11
14:11
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
14:11Amir Shroufi discusses the early results assessing the safety and efficacy of the combination of bedaquiline and delamanid against drug-resistant tuberculosis. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.…
…
continue reading

1
MERS and transchromosomic cows: The Lancet Infectious Diseases: January 10, 2018
12:00
12:00
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
12:00John Beigel, an author, and Eddie Sullivan discuss a phase 1 study assessing the safety and tolerability of human antibodies manufactured in transchromosomic cows for treatment of MERS. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedica…
…
continue reading

1
MERS and transchromosomic cows: The Lancet Infectious Diseases: January 10, 2018
12:48
12:48
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
12:48John Beigel, an author, and Eddie Sullivan discuss a phase 1 study assessing the safety and tolerability of human antibodies manufactured in transchromosomic cows for treatment of MERS.بقلم The Lancet
…
continue reading

1
PrEP in the UK: The Lancet Infectious Diseases: October 17, 2017
6:33
6:33
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
6:33Valentina Cambiano discusses the cost-effectiveness of pre-exposure prophylaxis medication in the UK. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv…
…
continue reading

1
PrEP in the UK: The Lancet Infectious Diseases: October 17, 2017
7:07
7:07
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
7:07Valentina Cambiano discusses the cost-effectiveness of pre-exposure prophylaxis medication in the UK.بقلم The Lancet
…
continue reading

1
Polio in Afghanistan: The Lancet Infectious Diseases: August 14, 2017
16:23
16:23
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
16:23Christina Wayman talks to Gillian SteelFisher about polio vaccination in Afghanistan.بقلم The Lancet
…
continue reading

1
Polio in Afghanistan: The Lancet Infectious Diseases: August 14, 2017
16:23
16:23
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
16:23Christina Wayman talks to Gillian SteelFisher about polio vaccination in Afghanistan. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv…
…
continue reading

1
Sexually transmitted infections: The Lancet Infectious Diseases: July 9, 2017
7:15
7:15
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
7:15Kit Fairley discusses The Lancet Infectious Diseases' new Commission on sexually transmitted infections.بقلم The Lancet
…
continue reading

1
Sexually transmitted infections: The Lancet Infectious Diseases: July 9, 2017
6:33
6:33
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
6:33Kit Fairley discusses The Lancet Infectious Diseases' new Commission on sexually transmitted infections. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv…
…
continue reading

1
Infectious diseases in China post-SARS: The Lancet Infectious Diseases: April 12, 2017
23:18
23:18
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
23:18In our latest Chinese-language podcast, Linjuan Li discusses the epidemiology and evolution of infectious diseases in China in the decade since SARS with Lancet editor Helena Wang.بقلم The Lancet
…
continue reading

1
Infectious diseases in China post-SARS: The Lancet Infectious Diseases: April 12, 2017
22:56
22:56
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
22:56In our latest Chinese-language podcast, Linjuan Li discusses the epidemiology and evolution of infectious diseases in China in the decade since SARS with Lancet editor Helena Wang. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljour…
…
continue reading

1
MCR-1 in bacteraemia in China: The Lancet Infectious Diseases: January 27, 2017
20:54
20:54
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
20:54In this special Chinese language podcast, Helena Wang is joined by two authors of papers on MCR-1 to discuss their research.بقلم The Lancet
…
continue reading

1
MCR-1 in bacteraemia in China: The Lancet Infectious Diseases: January 27, 2017
20:45
20:45
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
20:45In this special Chinese language podcast, Helena Wang is joined by two authors of papers on MCR-1 to discuss their research. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://yout…
…
continue reading

1
Inequities in Australian infectious diseases: The Lancet Infectious Diseases: 24 October
7:47
7:47
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
7:47Katherine Gibney discusses her paper on geographic variations and sociodemographic inequities in infectious disease notifications in Australia.بقلم The Lancet
…
continue reading

1
Inequities in Australian infectious diseases: The Lancet Infectious Diseases: 24 October
7:38
7:38
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
7:38Katherine Gibney discusses her paper on geographic variations and sociodemographic inequities in infectious disease notifications in Australia. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-…
…
continue reading

1
TB Screening: The Lancet Infectious Diseases: March 21, 2016
10:51
10:51
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
10:51Rob Aldridge discusses the prevalence of and risk factors for tuberculosis in UK migrant.بقلم The Lancet
…
continue reading

1
TB Screening: The Lancet Infectious Diseases: March 21, 2016
9:49
9:49
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
9:49Rob Aldridge discusses the prevalence of and risk factors for tuberculosis in UK migrant. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv…
…
continue reading